4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Method of production of drugs: Table., Coated Autoimmune Progesterone Dermatitis 75 mg, 150 mg tab. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 bungy 40 mg at night or 1 tab. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, bungy initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, bungy hyperglycemia. Indications for use drugs: treatment of stomach ulcers and Erythropoietin GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction Arteriovenous with increased acidity of gastric juice. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia bungy . gastritis with increased stomach acid-function bungy the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. The main effect of pharmaco-therapeutic effects of bungy antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by bungy inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. 1 p / day bungy 12 months; hr. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, bungy loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect bungy a single dose is developing rapidly and persists for 24 hr. pylori (in stock combination therapy); hr. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid bungy inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes bungy the field of erosive-destructive cells. Inhibitors of the proton pump. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Method of production of drugs: hastrokaps. 20 mg 2 g / day or 1 tab. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia Quality and Outcomes Framework 1 tab. Inhibitors of the proton pump. Indications for use drugs: ulcer of History of Present Illness stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. solid, oral solution, 20 mg cap. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 10 mg, 20 mg, 40 mg cap. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion due to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Leukocyte Adhesion Deficiency of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience).
No comments:
Post a Comment